Noesis Capital Mangement Corp Danaher Corp Transaction History

Noesis Capital Mangement Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$239.75 - $277.0 $3,836 - $4,432	-16 Reduced 1.76%	894 $225 Million
Q4 2022 Feb 02, 2023	BUY	$241.42 - $282.29 $30,660 - $35,850	127 Added 16.22%	910 $242 Million
Q3 2022 Nov 01, 2022	BUY	$247.06 - $1507.4 $193,447 - $1.18 Million	783 New	783 $202 Million
Q2 2022 Jul 29, 2022	SELL	$237.11 - $299.66 $171,430 - $216,654	-723 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$257.27 - $315.76 $6,689 - $8,209	-26 Reduced 3.47%	723 $212,000
Q4 2021 Feb 03, 2022	SELL	$292.08 - $329.01 $55,495 - $62,511	-190 Reduced 20.23%	749 $246,000
Q3 2021 Nov 04, 2021	BUY	$272.21 - $332.43 $255,605 - $312,151	939 New	939 $285,000

2,509

540M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $174B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

Stay updated on Noesis Capital Mangement Corp with notifications on news.